Suggestions

最新刊期
      期 16 ， 2021
      • DOI: 10.3969/j.issn.1674-7860.2021.16.010
        摘要：PFIC is an autosomal recessive inherited hepatocellular cholestasis, which is a rare disease. The diagnosis and treatment of a patient with PFIC with gallbladder disease was summarized. It is the first to confirm that PFIC combined with gallbladder disease s genetically related, and the condition has been significantly improved after treatment with Qi (气) acupuncture of TCM. A powerful eference for future diagnosis and treatment was provided.  
        关键词：PFIC type 3;Gallbladder disease type 1;The Qi-acupuncture therapy of TCM;The integrative medicine   
        133
        |
        26
        |
        0
        <HTML>
        <L-PDF><Meta-XML>
        <引用本文> <批量引用> 19772276 false
        发布时间：2021-11-02
      • ZHANG Xiaogang,HU Shuaihang,TIAN Peiyu,HOU Wei
        DOI: 10.13288/j.11-2166/r.2021.16.004
        摘要：This paper summarized professor PIAO Bingkui's commonly used drug groups in treating tumors, and discussed his thoughts in clinical practice and academic researches. It is believed that the core disease mechanism of tumor should be considered as two aspects, deficiency and excess, and healthy qi deficiency is the basis of tumor pathogenesis. Therefore, reinforcing healthy qi and fostering the root is considered as the core treatment principle in clinical practice, and correspondingly drug groups are formulated including Huangqi (Radix Astragali), Danggui (Radix Angelicae Sinensis), Nuzhenzi (Fructus Ligustri Lucidi), Gouqizi (Fructus Lycii) to reinforce healthy qi and foster root, as well as Chenpi (Pericarpium Citri Reticulatae), Chaoshanzha (fried Fructus Crataegi), Chaoshenqu (fried Massa Medicata Fermentata), and Chaomaiya (dried Fructus Hordei Germinatus) to protect stomach and activate spleen. Simultaneously, the drug groups target to tumors in different parts can be developed after fully considering the tumor specifics and the physiological characteristics of related zang-fu organs (脏腑), such as the drug group of Shashen (Radix Adenophorae seu Glehniae), Jiegeng (Radix Platycodonis), Maidong (Radix Ophiopogonis) and Kuxinren (Semen Armeniacae Amarum) for lung cancer; the group of Jixingzi (Semen Impatientis), Baihua Sheshe Cao (Herba Hedyotis Diffusae), Tufuling (Rhizoma Smilacis Glabrae) and Ezhu (Rhizoma Curcumae) for esophageal cancer; the group of Baizhu (Rhizoma Atractylodis Macrocephalae), Shanyao (Rhizoma Dioscoreae), Zhiqiao (Fructus Aurantii) and Yizhiren (Fructus Alpiniae Oxyphyllae) for stomach cancer and colorectal cancer; the drug group of Beichaihu (Bupleurum chinense DC.), Baishao (Radix Paeoniae Alba), Zhiqiao and Gancao (Radix et Rhizoma Glycyrrhizae) for ovarian cancer and breast cancer; the drug group of Weilingxian (Radix et Rhizoma Clematidis), Xuduan (Radix Dipsaci), Niuxi (Radix Achyranthis Bidentatae) and Gusuibu (Rhizoma Drynariae) for bone tumor; and the group of Tiandong (Radix Asparagi), Chaishao (Radix Paeoniae Rubra), Xuanshen (Radix Scrophulariae) and Beishashen (Radix Glehniae) for nasopharyngeal carcinoma.  
        关键词：tumors;drug groups;experience of famous doctor's;PIAO Bingkui   
        21
        |
        12
        |
        0
        <HTML>
        <L-PDF><Meta-XML>
        <引用本文> <批量引用> 19772249 false
        发布时间：2021-11-02
      0